Research ArticleArticle
Quantitative Cytochrome P450 3A4 Induction Risk Assessment Using Human Hepatocytes Complemented with Pregnane X Receptor-Activating Profiles
Aynur Ekiciler, Wen Li Kelly Chen, Yan Bo, Alessandra Pugliano, Massimiliano Donzelli, Neil Parrott and Kenichi Umehara
Drug Metabolism and Disposition March 2023, 51 (3) 276-284; DOI: https://doi.org/10.1124/dmd.122.001132
Aynur Ekiciler
Roche Pharmaceutical Research and Early Development, Roche Innovation Center Basel, Basel, Switzerland (A.E., A.P., M.D., N.P., K.U.) and Roche Pharmaceutical Research and Early Development, China Innovation Center of Roche, Shanghai, China (W.L.K.C., Y.B.)
Wen Li Kelly Chen
Yan Bo
Alessandra Pugliano
Massimiliano Donzelli
Neil Parrott
Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Research ArticleArticle
Evaluation of CYP3A4 Induction Incorporating PXR Activation
Aynur Ekiciler, Wen Li Kelly Chen, Yan Bo, Alessandra Pugliano, Massimiliano Donzelli, Neil Parrott and Kenichi Umehara
Drug Metabolism and Disposition March 1, 2023, 51 (3) 276-284; DOI: https://doi.org/10.1124/dmd.122.001132
Research ArticleArticle
Evaluation of CYP3A4 Induction Incorporating PXR Activation
Aynur Ekiciler, Wen Li Kelly Chen, Yan Bo, Alessandra Pugliano, Massimiliano Donzelli, Neil Parrott and Kenichi Umehara
Drug Metabolism and Disposition March 1, 2023, 51 (3) 276-284; DOI: https://doi.org/10.1124/dmd.122.001132
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement